Maurits Roorda

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Saccharomyces Cerevisiae

Breast Cancer Cells

Top Venues

G3 (Bethesda, Md.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Christy Hong, Michael Schubert, Andréa E Tijhuis, Marta Requesens, Maurits Roorda, Anouk van den Brink, Lorena Andrade Ruiz, Petra L Bakker, Tineke van der Sluis, Wietske Pieters, Mengting Chen, Rene Wardenaar, Bert Van der Vegt, Diana Carolina Johanna Spierings, Marco de Bruyn, Marcel A T M van Vugt, Floris Foijer
cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature 607 (7918) (2022)
Dario Zimmerli, Chiara S Brambillasca, Francien Talens, Jinhyuk Bhin, Renske Linstra, Lou Romanens, Arkajyoti Bhattacharya, Stacey E P Joosten, Ana Moises Da Silva, Nuno Padrao, Max D Wellenstein, Kelly Kersten, Mart de Boo, Maurits Roorda, Linda Henneman, Roebi de Bruijn, Stefano Annunziato, Eline van der Burg, Anne Paulien Drenth, Catrin Lutz, Theresa Endres, Marieke van de Ven, Martin Eilers, Lodewyk F A Wessels, Karin E de Visser, Wilbert Zwart, Rudolf S N Fehrmann, Marcel A T M van Vugt, Jos Jonkers
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Nature communications 13 (1) (2022)
Lin Zhou, Siqi Zheng, Fernando Rodrigo Rosas Bringas, Bjorn Bakker, Judith E Simon, Petra L Bakker, Hinke G Kazemier, Michael Schubert, Maurits Roorda, Marcel A T M van Vugt, Michael Chang, Floris Foijer
A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers. G3 (Bethesda, Md.) 11 (12) (2022)